Metal-organic Nanopharmaceuticals

Benjamin       Steinborn; Ulrich       Lächelt

doi:10.2174/2211738508666200421113215

Abstract

Coordinative interactions between multivalent metal ions and drug derivatives with Lewis base functions give rise to nanoscale coordination polymers (NCPs) as delivery systems. As the pharmacologically active agent constitutes a main building block of the nanomaterial, the resulting drug loadings are typically very high. By additionally selecting metal ions with favorable pharmacological or physicochemical properties, the obtained NCPs are predominantly composed of active components which serve individual purposes, such as pharmacotherapy, photosensitization, multimodal imaging, chemodynamic therapy or radiosensitization. By this approach, the assembly of drug molecules into NCPs modulates pharmacokinetics, combines pharmacological drug action with specific characteristics of metal components and provides a strategy to generate tailorable multifunctional nanoparticles. This article reviews different applications and recent examples of such highly functional nanopharmaceuticals with a high ‘material economy’.

Lay Summary: Nanoparticles, that are small enough to circulate in the bloodstream and can carry cargo molecules, such as drugs, imaging or contrast agents, are attractive materials for pharmaceutical applications. A high loading capacity is a generally aspired parameter of nanopharmaceuticals to minimize patient exposure to unnecessary nanomaterial. Pharmaceutical agents containing Lewis base functions in their molecular structure can directly be assembled into metal-organic nanopharmaceuticals by coordinative interaction with metal ions. Such coordination polymers generally feature extraordinarily high loading capacities and the flexibility to encapsulate different agents for a simultaneous delivery in combination therapy or ‘theranostic’ applications.

Keywords: Cancer therapy, drug delivery, metal-organic frameworks, nanopharmaceuticals, nanoscale coordination polymers, photodynamic therapy, radiotherapy, theranostics.

« Previous Next »

Graphical Abstract

[1] 
Moghadam PZ, Li A, Wiggin SB, et al. Development of a cambridge structural database subset: a collection of metal-organic frameworks for past, present, and future. Chem Mater  2017; 29(7): 2618-25.
[http://dx.doi.org/10.1021/acs.chemmater.7b00441] 
[2] 
He C, Liu D, Lin W. Nanomedicine applications of hybrid nanomaterials built from metal-ligand coordination bonds: nanoscale metal-organic frameworks and nanoscale coordination polymers. Chem Rev  2015; 115(19): 11079-108.
[http://dx.doi.org/10.1021/acs.chemrev.5b00125] [PMID:  26312730] 
[3] 
Freund R, Lächelt U, Gruber T, Rühle B, Wuttke S. Multifunctional efficiency: extending the concept of atom economy to functional nanomaterials. ACS Nano  2018; 12(3): 2094-105.
[http://dx.doi.org/10.1021/acsnano.8b00932] [PMID:  29533060] 
[4] 
Batten SR, Champness NR, Chen X-M, et al. Coordination polymers, metal-organic frameworks and the need for terminology guidelines. CrystEngComm  2012; 14(9): 3001-4.
[http://dx.doi.org/10.1039/c2ce06488j] 
[5] 
Batten SR, Champness NR, Chen X-M, et al. Terminology of metal-organic frameworks and coordination polymers (IUPAC Recommendations 2013). Pure Appl Chem  2013; 85(8): 1715-24.
[http://dx.doi.org/10.1351/PAC-REC-12-11-20] 
[6] 
Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer  2012; 12(4): 278-87.
[http://dx.doi.org/10.1038/nrc3236] [PMID:  22437872] 
[7] 
Baudino TA. Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol  2015; 12(1): 3-20.
[http://dx.doi.org/10.2174/1570163812666150602144310] [PMID:  26033233] 
[8] 
Velcheti V, Schalper K. Basic overview of current immunotherapy approaches in cancer. American Society
  of Clinical Oncology educational book American
  Society of Clinical Oncology Annual Meeting.  35 : 298-308 .
[9] 
Golombek SK, May J-N, Theek B, et al. Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev  2018; 130: 17-38.
[http://dx.doi.org/10.1016/j.addr.2018.07.007] [PMID:  30009886] 
[10] 
Rahman AM, Yusuf SW, Ewer MS. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine  2007; 2(4): 567-83.
[PMID:  18203425] 
[11] 
Franco YL, Vaidya TR, Ait-Oudhia S. Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer. Breast Cancer  2018; 10: 131-41.
[http://dx.doi.org/10.2147/BCTT.S170239] [PMID:  30237735] 
[12] 
Gyongyosi M, Lukovic D, Zlabinger K, et al. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance. Cardiovasc Res  2020; 116(5): 970-82.
[http://dx.doi.org/10.1093/cvr/cvz192] [PMID:  31346605] 
[13] 
Cheung BC, Sun TH, Leenhouts JM, Cullis PR. Loading of doxorubicin into liposomes by forming Mn2+-drug complexes. Biochim Biophys Acta  1998; 1414(1-2): 205-16.
[http://dx.doi.org/10.1016/S0005-2736(98)00168-0] [PMID:  9804955] 
[14] 
Kheirolomoom A, Ingham ES, Commisso J, Abushaban N, Ferrara KW. Intracellular trafficking of a pH-responsive drug metal complex. J Control Release  2016; 243: 232-42.
[http://dx.doi.org/10.1016/j.jconrel.2016.10.012] [PMID:  27746275] 
[15] 
Kheirolomoom A, Mahakian LM, Lai CY, et al. Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm  2010; 7(6): 1948-58.
[http://dx.doi.org/10.1021/mp100245u] [PMID:  20925429] 
[16] 
Xing L, Zheng H, Che S. A pH-responsive cleavage route based on a metal-organic coordination bond. Chemistry  2011; 17(26): 7271-5.
[http://dx.doi.org/10.1002/chem.201003005] [PMID:  21567490] 
[17] 
Imaz I, Rubio-Martínez M, García-Fernández L, et al. Coordination polymer particles as potential drug delivery systems. Chem Commun (Camb)  2010; 46(26): 4737-9.
[http://dx.doi.org/10.1039/c003084h] [PMID:  20485835] 
[18] 
He Z, Zhang P, Xiao Y, Li J, Yang F, Liu Y, et al. Acid-degradable gadolinium-based nanoscale coordination polymer: a potential platform for targeted drug delivery and potential magnetic resonance imaging. Nano Res  2018; 11(2): 929-39.
[http://dx.doi.org/10.1007/s12274-017-1705-1] 
[19] 
Tang L, Shi J, Wang X, et al. Coordination polymer nanocapsules prepared using metal-organic framework templates for pH-responsive drug delivery. Nanotechnology  2017; 28(27): 275601
[http://dx.doi.org/10.1088/1361-6528/aa7379] [PMID:  28510533] 
[20] 
Gao PF, Zheng LL, Liang LJ, Yang XX, Li YF, Huang CZ. A new type of pH-responsive coordination polymer sphere as a vehicle for targeted anticancer drug delivery and sustained release. J Mater Chem B Mater Biol Med  2013; 1(25): 3202-8.
[http://dx.doi.org/10.1039/c3tb00026e] [PMID:  32260920] 
[21] 
Zhao J, Yang Y, Han X, et al. Redox-sensitive nanoscale coordination polymers for drug delivery and cancer theranostics. ACS Appl Mater Interfaces  2017; 9(28): 23555-63.
[http://dx.doi.org/10.1021/acsami.7b07535] [PMID:  28636308] 
[22] 
Han K, Zhang W-Y, Zhang J, Ma Z-Y, Han H-Y. pH-responsive nanoscale coordination polymer for efficient drug delivery and real-time release monitoring. Adv Healthc Mater  2017; 6(19): 1700470
[http://dx.doi.org/10.1002/adhm.201700470] [PMID:  28714280] 
[23] 
Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr  2013; 32(6): 894-903.
[http://dx.doi.org/10.1016/j.clnu.2013.03.008] [PMID:  23582951] 
[24] 
Liu J, Yang G, Zhu W, et al. Light-controlled drug release from singlet-oxygen sensitive nanoscale coordination polymers enabling cancer combination therapy. Biomaterials  2017; 146: 40-8.
[http://dx.doi.org/10.1016/j.biomaterials.2017.09.007] [PMID:  28941551] 
[25] 
Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet  2017; 389(10066): 299-311.
[http://dx.doi.org/10.1016/S0140-6736(16)30958-8] [PMID:  27574741] 
[26] 
Cortez AJ, Tudrej P, Kujawa KA, Lisowska KM. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol  2018; 81(1): 17-38.
[http://dx.doi.org/10.1007/s00280-017-3501-8] [PMID:  29249039] 
[27] 
Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer  2007; 7(8): 573-84.
[http://dx.doi.org/10.1038/nrc2167] [PMID:  17625587] 
[28] 
Tapia G, Diaz-Padill I. Molecular mechanisms of platinum resistance in ovarian cancer.  United Kingdom: InTech 2013; pp. 205-23.
[http://dx.doi.org/10.5772/55562] 
[29] 
Rieter WJ, Pott KM, Taylor KM, Lin W. Nanoscale coordination polymers for platinum-based anticancer drug delivery. J Am Chem Soc  2008; 130(35): 11584-5.
[http://dx.doi.org/10.1021/ja803383k] [PMID:  18686947] 
[30] 
Liu D, Poon C, Lu K, He C, Lin W. Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy. Nat Commun  2014; 5: 4182.
[http://dx.doi.org/10.1038/ncomms5182] [PMID:  24964370] 
[31] 
Poon C, He C, Liu D, Lu K, Lin W. Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer. J Control Release  2015; 201: 90-9.
[http://dx.doi.org/10.1016/j.jconrel.2015.01.026] [PMID:  25620067] 
[32] 
He C, Poon C, Chan C, Yamada SD, Lin W. Nanoscale coordination polymers codeliver chemotherapeutics and siRNAs to eradicate tumors of cisplatin-resistant ovarian cancer. J Am Chem Soc  2016; 138(18): 6010-9.
[http://dx.doi.org/10.1021/jacs.6b02486] [PMID:  27088560] 
[33] 
Liu J, Chen Q, Zhu W, et al. Nanoscale-coordination-polymer-shelled manganese dioxide composite nanoparticles: a multistage redox/pH/H2O2-responsive cancer theranostic nanoplatform. Adv Funct Mater  2017; 27(10): 1605926
[http://dx.doi.org/10.1002/adfm.201605926] 
[34] 
Adarsh NN, Frias C, Ponnoth Lohidakshan TM, et al. Pt(IV)-based nanoscale coordination polymers: antitumor activity, cellular uptake and interactions with nuclear DNA. Chem Eng J  2018; 340: 94-102.
[http://dx.doi.org/10.1016/j.cej.2018.01.058] 
[35] 
Yang Y, Xu L, Zhu W, et al. One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy. Biomaterials  2018; 156: 121-33.
[http://dx.doi.org/10.1016/j.biomaterials.2017.11.038] [PMID:  29195181] 
[36] 
Hu Y, Lv T, Ma Y, et al. Nanoscale coordination polymers for synergistic NO and chemodynamic therapy of liver cancer. Nano Lett  2019; 19(4): 2731-8.
[http://dx.doi.org/10.1021/acs.nanolett.9b01093] [PMID:  30919635] 
[37] 
Huxford RC, Dekrafft KE, Boyle WS, Liu D, Lin W. Lipid-coated nanoscale coordination polymers for targeted delivery of antifolates to cancer cells. Chem Sci (Camb)  2012; 3(1): 198-204.
[http://dx.doi.org/10.1039/C1SC00499A] [PMID:  24288587] 
[38] 
Steinborn B, Hirschle P, Höhn M, et al. Core-shell functionalized zirconium‐pemetrexed coordination nanoparticles as carriers with a high drug content. Adv Ther  2019; 2(11): 1900120
[http://dx.doi.org/10.1002/adtp.201900120] 
[39] 
Liu D, He C, Poon C, Lin W. Theranostic nanoscale coordination polymers for magnetic resonance imaging and bisphosphonate delivery. J Mater Chem B Mater Biol Med  2014; 2(46): 8249-55.
[http://dx.doi.org/10.1039/C4TB00751D] [PMID:  32262098] 
[40] 
Thomsen HS. Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin North Am  2009; 47(5): 827-31.  vi.
[http://dx.doi.org/10.1016/j.rcl.2009.05.003] [PMID: 19744597] 
[41] 
Pan D, Schmieder AH, Wickline SA, Lanza GM. Manganese-based MRI contrast agents: past, present and future. Tetrahedron  2011; 67(44): 8431-44.
[http://dx.doi.org/10.1016/j.tet.2011.07.076] [PMID:  22043109] 
[42] 
Daniell MD, Hill JS. A history of photodynamic therapy. Aust N Z J Surg  1991; 61(5): 340-8.
[http://dx.doi.org/10.1111/j.1445-2197.1991.tb00230.x] [PMID:  2025186] 
[43] 
Drugs@FDA: FDA-Approved Drugs. U.S. food and
 drug administration.   Available from:   https://www. accessdata.fda.gov/scripts/cder/daf/index.cfmevent=overview.process&ApplNo=020451.
[44] 
Lismont M, Dreesen L, Wuttke S. Metal-organic framework nanoparticles in photodynamic therapy: current status and perspectives. Adv Funct Mater  2017; 27(14): 1606314
[http://dx.doi.org/10.1002/adfm.201606314] 
[45] 
Lu K, He C, Lin W. Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer. J Am Chem Soc  2014; 136(48): 16712-5.
[http://dx.doi.org/10.1021/ja508679h] [PMID:  25407895] 
[46] 
Lu K, He C, Lin W. A chlorin-based nanoscale metal-organic framework for photodynamic therapy of colon cancers. J Am Chem Soc  2015; 137(24): 7600-3.
[http://dx.doi.org/10.1021/jacs.5b04069] [PMID:  26068094] 
[47] 
Yang Y, Zhu W, Feng L, et al. G-quadruplex-based nanoscale coordination polymers to modulate tumor hypoxia and achieve nuclear-targeted drug delivery for enhanced photodynamic therapy. Nano Lett  2018; 18(11): 6867-75.
[http://dx.doi.org/10.1021/acs.nanolett.8b02732] [PMID:  30303384] 
[48] 
Liu J, Yang Y, Zhu W, et al. Nanoscale metal-organic frameworks for combined photodynamic & radiation therapy in cancer treatment. Biomaterials  2016; 97: 1-9.
[http://dx.doi.org/10.1016/j.biomaterials.2016.04.034] [PMID:  27155362] 
[49] 
Prencipe G, Tabakman SM, Welsher K, et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc  2009; 131(13): 4783-7.
[http://dx.doi.org/10.1021/ja809086q] [PMID:  19173646] 
[50] 
He C, Liu D, Lin W. Self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers. ACS Nano  2015; 9(1): 991-1003.
[http://dx.doi.org/10.1021/nn506963h] [PMID:  25559017] 
[51] 
de-Krafft KE, Xie Z, Cao G, et al. Iodinated nanoscale coordination polymers as potential contrast agents for computed tomography. Angew Chem Int Ed Engl  2009; 48(52): 9901-4.
[http://dx.doi.org/10.1002/anie.200904958] [PMID:  19937883] 
[52] 
Heismann BJ, Leppert J, Stierstorfer K. Density and atomic number measurements with spectral x-ray attenuation method. J Appl Phys  2003; 94(3): 2073-9.
[http://dx.doi.org/10.1063/1.1586963] 
[53] 
Lusic H, Grinstaff MW. X-ray-computed tomography contrast agents. Chem Rev  2013; 113(3): 1641-66.
[http://dx.doi.org/10.1021/cr200358s] [PMID:  23210836] 
[54] 
Solórzano R, Tort O, García-Pardo J, et al. Versatile iron-catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy. Biomater Sci  2018; 7(1): 178-86.
[http://dx.doi.org/10.1039/C8BM01221K] [PMID:  30507990] 
[55] 
Chao Y, Liang C, Yang Y, et al. Highly effective radioisotope cancer therapy with a non-therapeutic isotope delivered and sensitized by nanoscale coordination polymers. ACS Nano  2018; 12(8): 7519-28.
[http://dx.doi.org/10.1021/acsnano.8b02400] [PMID:  30047272] 
[56] 
Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater  2017; 29(32)
[http://dx.doi.org/10.1002/adma.201700996] [PMID:  28643452] 
[57] 
Heck JG, Feldmann C. Zirconyl acetaminophen phosphate: a nanoscaled analgetic with very high drug load. J Colloid Interface Sci  2016; 481: 69-74.
[http://dx.doi.org/10.1016/j.jcis.2016.07.030] [PMID:  27451036] 
[58] 
Wang K, Ma X, Shao D, Geng Z, Zhang Z, Wang Z. Coordination-induced assembly of coordination polymer submicrospheres: promising antibacterial and in vitro anticancer activities. Cryst Growth Des  2012; 12(7): 3786-91.
[http://dx.doi.org/10.1021/cg3006162] 
[59] 
Yang Y, Chao Y, Liu J, Dong Z, He W, Zhang R, et al. Core-shell and co-doped nanoscale metal-organic particles (NMOPs) obtained via post-synthesis cation exchange for multimodal imaging and synergistic thermo-radiotherapy. NPG Asia Mater  2017; 9(1): e344
[60] 
Jin Q, Zhu W, Jiang D, et al. Ultra-small iron-gallic acid coordination polymer nanoparticles for chelator-free labeling of 64Cu and multimodal imaging-guided photothermal therapy. Nanoscale  2017; 9(34): 12609-17.
[http://dx.doi.org/10.1039/C7NR03086J] [PMID:  28825066] 
[61] 
Steinberg I, Huland DM, Vermesh O, Frostig HE, Tummers WS, Gambhir SS. Photoacoustic clinical imaging. Photoacoustics  2019; 14: 77-98.
[http://dx.doi.org/10.1016/j.pacs.2019.05.001] [PMID:  31293884] 
[62] 
Amorin-Ferre L, Novio F, Simmchen J, Vazquez Mera N, Ruiz-Molina D. Coordination polymer nanoparticles in medicine  2013; 257(19-20): 2839-47.

Rights & Permissions Print Cite

Article Metrics

30

2

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/2211738508666200421113215	Print ISSN 2211-7385
Publisher Name Bentham Science Publisher	Online ISSN 2211-7393

Pharmaceutical Nanotechnology

Metal-organic Nanopharmaceuticals

Abstract

Graphical Abstract

Polymeric nanocarriers in drug delivery

Pharmaceutical Nanotechnology

Metal-organic Nanopharmaceuticals

Abstract Play Pause

Graphical Abstract

Call for Papers in Thematic Issues

Polymeric nanocarriers in drug delivery

Related Journals

Related Books

Related Articles

Abstract